Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/EJE-08-0931
European Journal of Endocrinology, Vol 161, Issue 1, 57-64
Copyright © 2009 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0931v1
161/1/57    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haugaard, S. B
Right arrow Articles by Madsbad, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haugaard, S. B
Right arrow Articles by Madsbad, S.
CLINICAL STUDY

Intramyocellular triglyceride content in man, influence of sex, obesity and glycaemic control

Steen B Haugaard1,2,3, Huiling Mu4, Allan Vaag5 and Sten Madsbad1

1 , Department of Endocrinology2 Clinical Research Centre, Copenhagen University Hospital, Hvidovre, DK-2650 Hvidovre, Denmark3 Department of Internal Medicine, Copenhagen University Hospital, Amager, DK-2300 Copenhagen, Denmark4 Department of Systems Biology, Technical University of Denmark, DK-2820 Lyngby, Denmark5 Steno Diabetes Centre, Copenhagen University, DK-2820 Gentofte, Denmark

(Correspondence should be addressed to S B Haugaard at Clinical Research Centre, Copenhagen University Hospital, Hvidovre Hospital, University of Copenhagen; Email: sbhau{at}dadlnet.dk)

Objective: It remains unknown whether sex impacts on intramyocellular triglyceride (IMTG) in obesity, as has been shown in non-obese subjects, and, if so, whether this may have implications on the association between IMTG and insulin sensitivity.

Subject and methods: A muscle biopsy from vastus lateralis was obtained in 27 obese women (body mass index (BMI)=35.5±0.8 kg/m2; mean±S.E.M., percentage of body fat (PBF)=44±1, n=7 impaired fasting glucose, n=7 type 2 diabetes), 20 obese men (BMI=35.8±0.8 kg/m2; PBF=33±1, n=4 impaired-fasting-glucose; n=6 type 2 diabetes) and 12 lean sedentary healthy individuals (controls; n=7 women, BMI=21.8±0.7 kg/m2, PBF=20±2; n=5 men, BMI=23.6±0.5 kg/m2, PBF=13±2). IMTG was determined by chromatography.

Results: IMTG was increased twofold in obese women compared to obese men, lean men and lean women respectively (21.9±2.4 mg/g wet weight, 10.9±1.5, 9.8±2.1 and 10.9±2.4 mg/g, P<0.001). Among obese subjects of either gender IMTG did not increase along with reduced glycaemic control in terms of impaired fasting glucose and diabetes. Plasma insulin levels, which were similar among obese women with different glycaemic control levels, but much lower in lean women, paralleled the changes in IMTG among women. PBF was associated with IMTG in all subjects (P<0.001). In a linear model, sex (P<0.05) and PBF (P<0.05) independently explained variation in IMTG. Plasma free fatty acids (FFA) correlated with IMTG in all subjects (P<0.005).

Conclusion: Obese women display twice as much IMTG as obese men matched for BMI. Increased IMTG could be a pathophysiological element or a mere physiological phenomenon in feminine obesity ensuing prior to impaired glycaemic control, but associated with increased body fat, circulating FFA and insulin.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 European Society of Endocrinology.